Fresenius Kabi
Products for chronically and critically ill patients
Fresenius Helios
Europe’s leading private healthcare provider
Archive "Stories"
Contact
Nick Stone Senior Vice President Investor Relations Head of Investor Relations
ir-fre@fresenius.com
Anke Schmidt Chief Communications Officer T +49 (0) 6172 686 495
anke.schmidt@fresenius.com
Share
Facebook
Twitter
LinkedIn
Xing
E-Mail
Services
Print
RSS
February 22, 2024 | London, UK
November 15, 2023 | Dublin, Ireland
November 30, 2023 | New York, USA
November 28, 2023 | Chicago, USA
November 29, 2023 | Boston, USA
November 03, 2023 | London, UK
October 11, 2023 | Edinburgh, UK
October 10, 2023 | London, UK
September 27, 2023 | Frankfurt, Germany
September 14, 2023 | Toronto, Canada